IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Breast Cancer: Targets and Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.55

h-Index

2022-2023

 38

Rank

2022-2023

 5618

SJR

2022-2023

 0.834

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Breast Cancer: Targets and Therapy
Abbreviation Breast Cancer: Targets Ther.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q2)
h-index 38
Overall Rank/Ranking 5618
SCImago Journal Rank (SJR) 0.834
Impact Score 2.55
Publisher Dove Medical Press Ltd.
Country New Zealand
ISSN 11791314
Best Quartile Q2
Coverage History 2010-2022




About Breast Cancer: Targets and Therapy


Breast Cancer: Targets and Therapy is a journal covering the technologies/fields/categories related to Oncology (Q2). It is published by Dove Medical Press Ltd.. The overall rank of Breast Cancer: Targets and Therapy is 5618. According to SCImago Journal Rank (SJR), this journal is ranked 0.834. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 38. The best quartile for this journal is Q2.

The ISSN of Breast Cancer: Targets and Therapy journal is 11791314. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Breast Cancer: Targets and Therapy is cited by a total of 465 articles during the last 3 years (Preceding 2022).


Breast Cancer: Targets and Therapy Impact IF 2022-2023


The Impact IF 2022 of Breast Cancer: Targets and Therapy is 2.55, which is computed in 2023 as per its definition. Breast Cancer: Targets and Therapy IF is decreased by a factor of 2.62 and approximate percentage change is -50.68% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Breast Cancer: Targets and Therapy Impact IF 2023 Prediction


Impact IF 2022 of Breast Cancer: Targets and Therapy is 2.55. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Breast Cancer: Targets and Therapy. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.55
2021 5.17
2020 4.93
2019 3.47
2018 2.91
2017 3.05
2016 3.84
2015 3.76
2014 1.33

Breast Cancer: Targets and Therapy h-index


  Table Setting

Breast Cancer: Targets and Therapy has an h-index of 38. It means 38 articles of this journal have more than 38 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Breast Cancer: Targets and Therapy ISSN


The ISSN of Breast Cancer: Targets and Therapy is 11791314. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Breast Cancer: Targets and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Breast Cancer: Targets and Therapy is 5618. According to SCImago Journal Rank (SJR), this journal is ranked 0.834. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Breast Cancer: Targets and Therapy by Year


Year SJR
2023/2024 Coming Soon
2022 0.834
2021 0.808
2020 1.190
2019 1.410
2018 1.186
2017 1.068
2016 1.378
2015 1.041
2014 0.344

Ranking of Breast Cancer: Targets and Therapy by Year


Year Ranking
2023/2024 Coming Soon
2022 5618
2021 5646
2020 3343
2019 2477
2018 3378
2017 3987
2016 2727
2015 4186
2014 11836

Breast Cancer: Targets and Therapy Publisher


Table Setting

Breast Cancer: Targets and Therapy is published by Dove Medical Press Ltd.. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2010-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Breast Cancer: Targets and Therapy is Breast Cancer: Targets Ther.. This abbreviation ('Breast Cancer: Targets Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Breast Cancer: Targets and Therapy


If your research field is/are related to Oncology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Breast Cancer: Targets and Therapy?

Breast Cancer: Targets and Therapy latest impact IF is 2.55. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.17 (2021) and 1.33 (2014), respectively, in the last 9 years. Moreover, its average IS is 3.45 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Breast Cancer: Targets and Therapy?

The Breast Cancer: Targets and Therapy has an SJR (SCImago Journal Rank) of 0.834, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.410 in 2019 and the lowest being 0.344 in 2014. Furthermore, the average SJR of the Breast Cancer: Targets and Therapy over the previous 9-year period stands at 3.45.


What's the latest h-index of the Breast Cancer: Targets and Therapy?

The latest h-index of the Breast Cancer: Targets and Therapy is 38.


Who's the publisher of the Breast Cancer: Targets and Therapy?

The Breast Cancer: Targets and Therapy is published by the Dove Medical Press Ltd., with its country of publication being the New Zealand.


What's the current ranking of the Breast Cancer: Targets and Therapy?

The Breast Cancer: Targets and Therapy is currently ranked 5618 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2477 in 2019 and its lowest position of 11836 in 2014.


What's the abbreviation or short name for the Breast Cancer: Targets and Therapy?

The standard ISO4 abbreviation for the Breast Cancer: Targets and Therapy is Breast Cancer: Targets Ther..


Is the "Breast Cancer: Targets and Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Breast Cancer: Targets and Therapy is classified as a journal that the Dove Medical Press Ltd. publishes.


What's the scope or major areas of the Breast Cancer: Targets and Therapy?

The Breast Cancer: Targets and Therapy encompasses the following areas:

  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Breast Cancer: Targets and Therapy?

The Breast Cancer: Targets and Therapy is assigned the following International Standard Serial Numbers (ISSN): 11791314.


What's the best quartile of the Breast Cancer: Targets and Therapy?

The best quartile for the Breast Cancer: Targets and Therapy is Q2 (2022).


What's the coverage history of the Breast Cancer: Targets and Therapy?

The Breast Cancer: Targets and Therapy coverage history can be summarized as follows: 2010-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Qualitative Research journal 2108 SAGE Publications Ltd 86 3.97
Journal of International Financial Management and Accounting journal 6179 Wiley-Blackwell Publishing Ltd 42 6.09
Discourse journal 6621 Routledge 59 2.11
British Journal of Special Education journal 12024 Wiley-Blackwell Publishing Ltd 42 1.24
European Journal of Education journal 6079 Wiley-Blackwell Publishing Ltd 53 2.31
Tekstilec trade journal 19217 Faculty of Natural Sciences and Engineering, Tekstilec 14 0.73
Population Review journal 17841 Sociological Demography Press 13 0.73
Asian Textile Journal trade journal 27455 G P S Kwatra 10 0.01
Oral Radiology journal 9461 Springer Japan 20 2.06
Proteomics - Clinical Applications journal 9140 Wiley-VCH Verlag 59 2.02

Check complete list




Year wise Impact Score (IS) of Breast Cancer: Targets and Therapy

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.55
2021 5.17
2020 4.93
2019 3.47
2018 2.91
2017 3.05
2016 3.84
2015 3.76
2014 1.33



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All